Boehringer Ingelheim and EFSD collaborate to support diabetes research in Europe
Lisbon, Portugal, 13th September, 2011 – Boehringer Ingelheim and the European Foundation for the Study of Diabetes (EFSD) today announced a new partnership to establish a €2.5 million research grant programme, encouraging diabetes research over the next three years.
The EFSD/Boehringer Ingelheim European Research Programme is intended to stimulate and accelerate research in Europe and encourage new projects aimed at advancing current knowledge in diabetes.
Diabetes is a condition that affects more and more people. "Therefore Boehringer Ingelheim is delighted to partner with the ESFD on this initiative, bringing together two organisations dedicated to improving the lives of people with diabetes", said Professor Klaus Dugi, Corporate Senior Vice President, Boehringer Ingelheim. "As part of our commitment to diabetes patients, we support research that will aid our understanding of the disease and ultimately help to improve therapeutic options for patients, and we hope this grant will support research that otherwise may not be possible."